Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated With Clinical Improvement in Chronic Graft Versus Host Disease
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2012.11.098
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2013
Authors
Publisher
Elsevier BV